Sirtuin-NAD Activator in Alzheimer's Disease

NCT05040321 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease (Incl Subtypes)
Dementia

Interventions

DRUG: MIB-626
DRUG: Placebo

Sponsor

Brigham and Women's Hospital